{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:56:58Z","timestamp":1766066218071,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T00:00:00Z","timestamp":1336521600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.6061\/clinics\/2012(sup01)17","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T17:56:33Z","timestamp":1335290193000},"page":"99-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"S1","title":["Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1"],"prefix":"10.1016","volume":"67","author":[{"suffix":"Jr.","given":"Delmar M","family":"Louren\u00e7o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia L.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo A.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Denck","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio L.M.","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio P.A.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.6061\/clinics\/2012(Sup01)17_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)17_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","article-title":"Primary hyperparathyroidism and the skeleton","volume":"69","author":"Mosekilde","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)17_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","article-title":"Primary hyperparathyroidism: a current perspective","volume":"132","author":"DeLellis","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/251410","article-title":"Primary hyperparathyroidism: an overview","author":"Mackenzie-Feder","year":"2011","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.6061\/clinics\/2012(Sup01)17_bib5","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib6","first-page":"N43","article-title":"Hyperparathyroidism in hereditary syndromes: special expression and special managements","volume":"17","author":"Marx","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)17_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","article-title":"Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1","volume":"246","author":"Tonelli","year":"2007","journal-title":"Ann Surg"},{"issue":"11","key":"10.6061\/clinics\/2012(Sup01)17_bib8","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00268-009-9924-6","article-title":"Familial parathyroid tumors: diagnosis and management","volume":"33","author":"St\u00e5lberg","year":"2009","journal-title":"World J Surg"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)17_bib9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.surg.2008.07.030","article-title":"Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism","volume":"144","author":"Yip","year":"2008","journal-title":"Surgery"},{"issue":"11","key":"10.6061\/clinics\/2012(Sup01)17_bib10","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Louren\u00e7o","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)17_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)17_bib12","first-page":"654","article-title":"Is surgery beneficial for MEN1 patients with small (< or \u200a=\u200a 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor","volume":"30","author":"Triponez","year":"2006","journal-title":"An analysis of 65 patients from the GTE. World J Surg"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)17_bib13","first-page":"542","article-title":"Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly","volume":"86","author":"Jorge","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)17_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)17_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/eje.1.02022","article-title":"Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease","volume":"153","author":"Dreijerink","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.6061\/clinics\/2012(Sup01)17_bib16","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/jc.2006-2394","article-title":"Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma","volume":"92","author":"Toledo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib17","first-page":"86","article-title":"Familial isolated pituitary adenoma: evidence for genetic heterogeneity","volume":"38","author":"Toledo","year":"2010","journal-title":"Front Horm Res"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)17_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S1807-59322010000400010","article-title":"Isolated familial somatotropinoma: 11q13-loh and gene\/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis","volume":"65","author":"Toledo","year":"2010","journal-title":"Clinics"},{"issue":"11","key":"10.6061\/clinics\/2012(Sup01)17_bib19","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"24","author":"Thakker","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)17_bib21","first-page":"529","article-title":"Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus","volume":"66","author":"Costa","year":"2011","journal-title":"Clinics"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)17_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mut"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)17_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2007.02895.x","article-title":"Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1","volume":"67","author":"Toledo","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)17_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/S1807-59322007000400014","article-title":"The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1","volume":"62","author":"Louren\u00e7o","year":"2007","journal-title":"Clinics"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)17_bib25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrc1610","article-title":"Molecular genetics of multiple endocrine neoplasia types 1 and 2","volume":"5","author":"Marx","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.6061\/clinics\/2012(Sup01)17_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncpendmet0292","article-title":"Mechanisms of disease: multiple endocrine neoplasia type 1 \u2014 relation to chromatin modifications and transcription regulation","volume":"2","author":"Dreijerink","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"9","key":"10.6061\/clinics\/2012(Sup01)17_bib27","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-05-4461","article-title":"Menin links estrogen receptor activation to histone H3K4 trimethylation","volume":"66","author":"Dreijerink","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)17_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2796.2009.02115.x","article-title":"Multiple endocrine neoplasia type 1: a chromatin writer's block","volume":"266","author":"Dreijerink","year":"2009","journal-title":"J Intern Med"},{"issue":"10","key":"10.6061\/clinics\/2012(Sup01)17_bib29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)17_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)17_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)17_bib32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry 2007 adult and pediatric official positions","volume":"43","author":"Lewiecki","year":"2008","journal-title":"Bone"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)17_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)17_bib34","first-page":"729","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.6061\/clinics\/2012(Sup01)17_bib35","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)17_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/EJE-08-0153","article-title":"Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile","volume":"159","author":"Louren\u00e7o","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.6061\/clinics\/2012(Sup01)17_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","article-title":"Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism","volume":"41","author":"Dempster","year":"2007","journal-title":"Bone"},{"issue":"3","key":"10.6061\/clinics\/2012(Sup01)17_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)17_bib39","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib40","article-title":"Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1","author":"Kann","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.6061\/clinics\/2012(Sup01)17_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2009.03672.x","article-title":"Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy","volume":"72","author":"Coutinho","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"17","key":"10.6061\/clinics\/2012(Sup01)17_bib42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib43","series-title":"GeneReviews [Internet]","article-title":"Multiple endocrine neoplasia type 1","author":"Falchetti","year":"1993"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(79)91062-3","article-title":"Clinical significance of primary hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I)","volume":"66","author":"Lamers","year":"1979","journal-title":"Am J Med"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)17_bib45","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1464-410X.2005.05731.x","article-title":"Familial multiple endocrine neoplasia type I: the urologist is first on the scene","volume":"96","author":"Christopoulos","year":"2005","journal-title":"BJU Int"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0753-3322(00)80020-7","article-title":"Clinical aspects of hyperparathyroidism in Japanese with multiple endocrine neoplasia type 1","volume":"54","author":"Sato","year":"2000","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.6061\/clinics\/2012(Sup01)17_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-2001-16944","article-title":"Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas","volume":"33","author":"Katai","year":"2001","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.6061\/clinics\/2012(Sup01)17_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2265.2000.01032.x","article-title":"Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1)","volume":"53","author":"Burgess","year":"2000","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.6061\/clinics\/2012(Sup01)17_bib49","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","article-title":"Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe d'Etude des N\u00e9oplasies Endocriniennes Multiples Study Group","volume":"25","author":"Goudet","year":"2001","journal-title":"World J Surg"},{"issue":"6","key":"10.6061\/clinics\/2012(Sup01)17_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncpendmet0816","article-title":"A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet","volume":"4","author":"Falchetti","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.6061\/clinics\/2012(Sup01)17_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/906163","article-title":"Clinical use of cinacalcet in MEN1 hyperparathyroidism","volume":"2010","author":"Moyes","year":"2010","journal-title":"Int J Endocrinol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222024036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222024036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-s1\/cln-67-s1-99.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:12:44Z","timestamp":1761721964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222024036"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012001300017&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3329618\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":51,"alternative-id":["S1807593222024036"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(sup01)17","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)17","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}